Swiss Patent Box Regime (StHG Art. 24a): Complete Guide to IP Tax Reduction in Switzerland

Switzerland's patent box — formally the Patentbox under Article 24a of the Tax Harmonisation Act (Steuerharmonisierungsgesetz, StHG) — allows companies holding qualifying intellectual property to reduce their cantonal taxable profit on IP income by up to 90%. Introduced as part of the 2020 Tax Reform and AHV Financing Act (TRAF), the regime replaced the former privileged holding and mixed company regimes that the OECD had designated as harmful. Unlike those legacy structures, the patent box is OECD-compliant: relief is linked to genuine R&D substance in Switzerland through the modified nexus approach. For IP-rich companies considering Switzerland, and for existing Swiss companies with patent portfolios, the regime can reduce the effective combined corporate income tax rate on qualifying IP income to roughly 8 to 10%. This guide covers the legal framework, qualifying rights, nexus calculation, R&D super-deduction, entry taxation, the Zug canton implementation, and the structural considerations for companies wishing to use the box.

Legal Framework: TRAF 2020 and StHG Art. 24a

The patent box entered Swiss law through the Federal Act on Tax Reform and AHV Financing (Bundesgesetz über die Steuerreform und die AHV-Finanzierung, STAF/TRAF), which was approved by Swiss voters in a referendum on 19 May 2019 and entered into force on 1 January 2020. TRAF was Switzerland's legislative response to sustained international pressure — from the OECD's BEPS project and the EU — to eliminate cantonal tax regimes that offered privileged rates without requiring genuine economic substance.

TRAF did two things simultaneously: it abolished the old regime (principal company status, mixed company rules, domicile companies) and replaced it with a menu of OECD-compliant measures that cantons were required to adopt. The patent box was mandatory: every Swiss canton had to introduce a patent box by 1 January 2020. The other TRAF measures — R&D super-deduction, notional interest deduction (NID), and transitional step-up relief — were optional, and cantons chose their own combinations.

StHG Art. 24a and 24b are the federal harmonisation template for the patent box. Art. 24a defines the qualifying IP categories; Art. 24b sets the maximum deduction (90%), mandates the nexus approach and governs entry taxation; and Art. 25b imposes the 70% combined relief cap. Cantons implement the box in their own cantonal tax laws, using these provisions as the minimum standard. Cantons may not offer more than 90% relief but may offer less, and they may narrow (but not widen) the definition of qualifying IP.

Federal direct tax (Direkte Bundessteuer, DBG) is entirely outside the patent box: the 8.5% federal flat rate on profit applies to the full taxable profit without any IP box adjustment. The box benefit is exclusively a cantonal and communal tax measure. For most Swiss companies, the cantonal and communal tax stack accounts for approximately 60–70% of the combined effective tax rate, so even a cantonal-only relief produces a material overall reduction.

Qualifying IP Rights Under the Swiss Patent Box

StHG Art. 24a defines qualifying IP by reference to specific legal frameworks rather than by general category. The following rights qualify:

• ●Swiss patents granted under the Swiss Patent Act of 25 June 1954 (Patentgesetz, PatG), including utility model registrations where applicable.
• ●European patents (EPC) granted under the European Patent Convention as revised on 29 November 2000, with extension to Switzerland, and corresponding national phase entries.
• ●Foreign patents that correspond to the above Swiss or EPC patents — meaning a foreign national patent covering the same invention as a qualifying Swiss or EPC patent. This allows multinational patent families to pool income in the box.
• ●Supplementary protection certificates (SPCs) extending the effective patent term for pharmaceutical and plant protection products beyond the standard 20-year patent term.
• ●Topography rights protecting the three-dimensional layout of semiconductor chip circuits.
• ●Plant varieties protected under Swiss plant variety protection law.
• ●Therapeutic product data exclusivity rights — data and documents protected under the Heilmittelgesetz (Therapeutic Products Act), which protect clinical trial data for pharmaceutical regulatory approval without a separate patent.

Software copyright as a standalone right does not qualify under the federal template, because Swiss patent law does not permit the grant of a patent for software as such (Art. 1a PatG). Software qualifies only if it forms part of a patented computer-implemented invention — in which case the qualifying right is the patent, and the software's contribution to the patent's functionality is captured indirectly. A small number of cantons have expanded their local definition to include copyright-protected software that functions as a patent-equivalent right in a foreign jurisdiction; the legal basis is disputed and companies should not rely on this without specific cantonal confirmation.

Trade marks, unregistered know-how, brand goodwill, and customer lists do not qualify. The box is limited to registered or registrable technical rights, not commercial or marketing assets. In mixed-product businesses where IP income includes both qualifying and non-qualifying contributions, the qualifying portion must be identified and separated for the nexus calculation.

The Nexus Approach: Calculating Box Profit

The modified nexus approach is the OECD-mandated mechanism (BEPS Action 5, 2015) that links patent box benefit to genuine R&D expenditure in Switzerland. It prevents companies from booking IP in Switzerland while conducting all development work abroad and then claiming the full box relief. Under the nexus approach, only the proportion of IP income traceable to qualifying Swiss R&D receives the deduction.

The calculation proceeds in three steps:

A worked example: a Zug company generates CHF 2,000,000 residual IP profit. It spent CHF 800,000 on in-house R&D in Switzerland and CHF 400,000 on contract R&D at a foreign affiliated lab. Total R&D is CHF 1,200,000. The 30% uplift on Swiss qualifying expenditure is CHF 240,000, but the uplift is capped at the actual outsourced amount of CHF 400,000 — so uplift is CHF 240,000. Qualifying expenditure after uplift: CHF 1,040,000. Nexus ratio: CHF 1,040,000 / CHF 1,200,000 = 86.7%. Box profit: CHF 2,000,000 × 86.7% = CHF 1,733,333. Cantonal deduction: CHF 1,733,333 × 90% = CHF 1,560,000. Cantonal taxable IP income: CHF 173,333 (plus the non-box residual of CHF 266,667). Subject to the 70% relief cap.

Companies with a high proportion of Swiss in-house R&D — particularly those with Swiss-resident engineers and researchers — maximise the nexus ratio and therefore the box benefit. Outsourcing significant R&D to foreign affiliates reduces the qualifying expenditure and the nexus ratio proportionally. This creates a structural incentive to locate at least the development phase of IP creation in Switzerland, which is consistent with the policy intent of BEPS Action 5.

R&D Super-Deduction: Up to 150% of Swiss R&D Costs

Separately from the patent box, TRAF permits cantons to grant an additional R&D super-deduction of up to 50% on qualifying Swiss R&D expenditure. This is an input-side incentive: it reduces taxable income on the basis of R&D costs incurred, regardless of whether those costs have yet generated any IP income or patent box profit. The super-deduction can therefore benefit companies in the development phase, before any qualifying IP is registered or generates royalty income.

The qualifying base for the R&D super-deduction includes:

• ●Swiss R&D personnel costs, grossed up by 35% to include mandatory employer social contributions (AHV/IV/EO). A company paying CHF 100,000 in gross R&D salaries grosses this up to CHF 135,000 before applying the super-deduction.
• ●Third-party Swiss R&D commissioned from unrelated Swiss research organisations, universities (ETH Zurich, EPFL, cantonal universities), or independent Swiss R&D providers — qualifying at 80% of the contract cost.
• ●Not qualifying: contract R&D from foreign affiliates, cost-sharing arrangements with group entities, and general overhead allocated to R&D. Only Swiss-based expenditure qualifies.

The 50% super-deduction is applied to the qualifying base after the grossing-up. For a company with CHF 1,000,000 in qualifying Swiss R&D personnel costs, the effective deductible amount is CHF 1,350,000 (grossed up) × 150% / 100% = effectively CHF 1,350,000 + CHF 675,000 extra deduction = CHF 2,025,000 total deduction from a CHF 1,000,000 cash cost. The super-deduction can be combined with the patent box in the same year, subject to the 70% combined relief cap under StHG Art. 25b.

Zug offers the maximum 50% R&D super-deduction. Several other cantons — including Obwalden, Zurich, and Geneva — also grant the full 50%. The measure is optional, and a number of cantons currently grant nothing: Nidwalden and Lucerne have the legal basis but set the rate at 0%, while Basel-Stadt and Appenzell Innerrhoden did not introduce an R&D super-deduction at all, relying instead on their ordinary rate and the patent box. Verify the current cantonal position annually, as cantonal tax laws may be amended (position as of 2026).

The 70% Relief Cap (StHG Art. 25b)

StHG Art. 25b imposes an absolute ceiling on combined TRAF tax relief. The aggregate benefit of the patent box, R&D super-deduction, and notional interest deduction (where available) may not reduce a company's cantonal taxable profit by more than 70% of the profit before these deductions. A minimum of 30% must remain taxable.

The cap applies per tax year and per cantonal entity, not per IP right or per measure. When a company's theoretical combined relief exceeds 70%, the excess is disallowed proportionally across the contributing measures. The disallowed relief is not carried forward; it is simply lost for that year.

The 70% floor also has an important structural consequence: companies that already benefit from a low base rate (Zug at 11.71%) derive proportionally less incremental benefit from TRAF measures than companies in high-tax cantons where the ordinary rate might be 19–20%. For a Zurich company (combined CIT approximately 19.61%), the 70% relief cap still leaves a much higher monetary saving per CHF of taxable income than for the same company in Zug. IP-rich companies must therefore weigh the base rate against the TRAF measure potential when selecting their Swiss canton.

Entry Taxation (Einlagebesteuerung) When Entering the Box

Entry taxation (Einlagebesteuerung) is the one-time tax charge that arises when a qualifying IP right is first allocated to the patent box regime. Swiss tax law requires that all R&D expenditure in respect of the IP that was deducted from taxable income in the preceding ten years be recaptured and added back to taxable income at the point of entry. The policy rationale is tax symmetry: the company previously benefited from deducting the development costs; it cannot then also receive the reduced IP income tax without first settling the deferred tax on those deductions.

In practice, entry taxation works as follows:

• ●Recapture amount: The total of all R&D costs deducted in the 10 years prior to first entry into the box for the specific IP right. This is tracked per-IP-right, not globally across all company R&D.
• ●Tax on recapture: The recaptured amount is added to ordinary cantonal taxable profit for the entry year and taxed at ordinary rates. For a Zug company, this is approximately 11.71% of the recaptured amount.
• ●Spreading: Some cantons permit the recapture charge to be spread over multiple years — typically 5 years — reducing the cash-flow impact significantly. The availability of spreading and the number of years over which it is available varies by canton. Zug's position should be confirmed with the Steuerverwaltung Zug at entry.
• ●Tax loss offset: Existing tax loss carryforwards (Verlustvorträge) can typically be applied to offset the entry charge, which is advantageous for early-stage companies that have accumulated losses from the R&D phase.
• ●New company advantage: An entity incorporated specifically to develop and hold IP, which has not previously deducted R&D costs, faces zero entry charge. This is a structural advantage of establishing a new Swiss IP entity rather than migrating existing IP into an established company.

For IP acquired from a related party and contributed to a Swiss entity, the entry value for the patent box must reflect the arm's-length value at the time of transfer (as determined by a transfer pricing analysis), not the historic cost. A hidden reserve in contributed IP (the excess of fair value over book value) may be subject to a transitional step-up charge under the TRAF transitional provisions. Planning the timing and structure of IP transfers with attention to the entry tax is essential and should involve a Swiss tax adviser familiar with transfer pricing.

Zug Patent Box: Canton-Specific Implementation

Zug is among Switzerland's lowest-tax cantons for corporate income, with a combined (federal + cantonal + communal) CIT rate of 11.85% for 2025 and 11.71% for 2026 (Lucerne, at about 11.66%, is marginally lower as of 2026). Within this already-low rate environment, Zug has implemented the patent box at the maximum permissible level and added the full R&D super-deduction, making the canton one of Europe's most competitive jurisdictions for IP-intensive companies.

Zug's cantonal tax law (Steuergesetz Zug, StG ZG) implements the patent box in line with StHG Art. 24a without restricting the qualifying IP categories beyond the federal template. Software copyright is not extended to qualify independently of a patent. The Zug tax authority (Steuerverwaltung Zug, Bahnhofstrasse 26, 6300 Zug) handles patent box applications for Zug-based entities and can provide advance rulings (Steuerrulings) confirming the applicable treatment for specific IP structures. Advance rulings are confidential, binding for the period of the ruling, and strongly recommended before implementing a patent box structure.

The combination of Zug's 11.71% ordinary rate, 90% patent box, and 50% R&D super-deduction makes it the leading Swiss canton for IP-holding structures. Goldblum & Partner AG, located at Baarerstrasse 25, 6300 Zug, regularly assists clients with Zug-based IP holding structures, patent box applications, and advance ruling requests with the Steuerverwaltung Zug. The firm's Zug location provides direct access to cantonal tax administration for structuring discussions.

Cantonal Comparison: Patent Box Implementation Across Switzerland

All 26 Swiss cantons were required to implement the patent box by 1 January 2020. Implementation quality and auxiliary measures vary. The table below covers the major cantons relevant to international IP structures.

Not every canton grants the full 90% patent box relief. Geneva and Appenzell Innerrhoden, for example, apply only a 10% reduction, and Appenzell Innerrhoden and Basel-Stadt grant no R&D super-deduction at all (all figures as of 2026). All cantonal rates should be verified annually, as communal multipliers within each canton vary by municipality and affect the combined rate. For Zug city specifically, the combined federal, cantonal and communal CIT rate is approximately 11.71% as of 2026 (11.85% in 2025); confirm the current municipal multiplier with the Steuerverwaltung Zug for the applicable tax year.

IP Structuring: Swiss IP Holding Company and R&D Subsidiary

The patent box is most efficient when combined with a deliberate IP structuring strategy. Two principal models are used:

Swiss IP holding company (with outsourced development): The Swiss entity owns the qualifying IP and holds the patent box position. Actual development work is contracted to affiliated or third-party entities (in Switzerland or abroad). The nexus ratio reflects the proportion of Swiss R&D in total R&D. This model is straightforward but limits the nexus ratio if significant development is offshore. The IP holding benefits from the holding company participation exemption on dividend income from subsidiaries and the absence of Swiss withholding tax on outbound royalties to qualifying treaty partners. See the overview of the Swiss holding company structure for the full participation exemption rules.

Swiss R&D and IP entity (integrated development): The Swiss entity conducts significant R&D in Switzerland using Swiss-resident employees or in collaboration with Swiss universities (ETH Zurich, EPFL, Zurich cantonal university, University of Lucerne). Patents arising from this work are registered in Switzerland and owned by the Swiss entity. The nexus ratio approaches 100% because most qualifying expenditure is Swiss. This structure maximises the patent box benefit, qualifies for the full R&D super-deduction, and generates genuine economic substance that satisfies both the nexus test and Swiss substance requirements for treaty access. It requires actual Swiss R&D personnel, Swiss laboratory or office infrastructure, and Swiss management of the R&D programme.

For regulated technology or life sciences companies, the IP structure must also coordinate with FINMA licensing requirements where relevant. See the guide to FINMA licences in Switzerland for the interface between IP ownership, trading activity, and Swiss financial regulation. For the underlying corporate income tax framework that sets the context for patent box planning, see the guide to Swiss corporate tax.

Interaction with Swiss Withholding Tax and Treaty Network

Switzerland imposes a 35% withholding tax (Verrechnungssteuer) on dividends paid by Swiss companies to foreign shareholders. Royalties paid by a Swiss company to a foreign recipient are not subject to Swiss withholding tax — outbound royalties from Switzerland are generally tax-free at source. This asymmetry means a Swiss IP holding company can receive royalties from foreign operating subsidiaries without the payors incurring Swiss withholding tax, which is a significant structural advantage compared to IP holding jurisdictions that impose withholding on outbound royalties.

The 35% withholding tax on dividends can be reduced to zero, 5%, or 15% under Switzerland's extensive network of double taxation treaties (approximately 100 bilateral treaties in force). Under the EU-Switzerland agreement on the taxation of savings and the bilateral treaties with EU member states, qualifying EU parent companies can receive Swiss dividends free of withholding under conditions that broadly mirror the EU Parent-Subsidiary Directive. Swiss WHT of 35% applies to dividends paid to non-treaty residents. For patent box structures where the Swiss entity will distribute earnings to a parent company, treaty eligibility of the parent jurisdiction is a material planning consideration.

Transfer pricing is the dominant compliance risk in patent box structures. The arm's-length standard (Drittvergleich) applies to all intra-group royalty rates, cost-sharing contributions, and IP transfer prices. The Swiss Federal Tax Administration (ESTV) does not publish formal safe harbours for intragroup royalties: each rate must be supportable by a contemporaneous transfer pricing study benchmarking against comparable uncontrolled transactions. The OECD Transfer Pricing Guidelines (particularly Chapter VI on intangibles) are the reference framework applied by Swiss tax authorities and courts.

For more on the Swiss corporate tax environment underlying the patent box, including the interaction of cantonal and federal rates, see the guide to Swiss corporate tax. For IP structures that involve financial service activities or collective investment vehicles, see the overview of FINMA licences. For the base company structure used in most Swiss IP holding arrangements, see the guide to the Swiss holding company.

Goldblum & Partner AG has advised technology companies, pharmaceutical groups, and industrial IP owners on Swiss patent box structures from Baarerstrasse 25, 6300 Zug since 2007. Our Zug-based team provides end-to-end support from formation through advance ruling, patent box entry, annual compliance, and transfer pricing documentation. Contact us for a free consultation on whether the Swiss patent box is the right structure for your IP.

Legal and tax note: Patent box calculations are fact-specific and depend on the company's R&D cost base, IP structure, nexus ratio, and cantonal implementation. Cantonal tax rates and communal multipliers change from year to year and should be confirmed with the relevant cantonal tax authority or a qualified Swiss tax adviser before any filing or structuring decision. The 70% relief cap, nexus ratio outcome, and entry tax charge must be computed on the specific facts of each case. This article does not constitute legal or tax advice and is provided for general information only.